IRIS
FRIES, Walter
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.726
EU - Europa 10.463
AS - Asia 5.316
SA - Sud America 1.863
Continente sconosciuto - Info sul continente non disponibili 460
AF - Africa 151
OC - Oceania 21
Totale 30.000
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.394
RU - Federazione Russa 5.139
SG - Singapore 2.410
BR - Brasile 1.589
CN - Cina 1.405
SE - Svezia 1.200
IE - Irlanda 1.169
HK - Hong Kong 627
FR - Francia 563
IT - Italia 560
DE - Germania 544
UA - Ucraina 383
GB - Regno Unito 329
VN - Vietnam 272
FI - Finlandia 230
PL - Polonia 118
CA - Canada 117
IN - India 101
BD - Bangladesh 97
AR - Argentina 90
MX - Messico 63
TR - Turchia 47
NL - Olanda 46
EC - Ecuador 44
ZA - Sudafrica 44
CO - Colombia 41
AT - Austria 40
IQ - Iraq 38
JP - Giappone 38
ID - Indonesia 32
ES - Italia 30
MA - Marocco 29
UZ - Uzbekistan 27
BE - Belgio 26
IL - Israele 26
VE - Venezuela 26
CR - Costa Rica 25
CL - Cile 21
JM - Giamaica 21
NI - Nicaragua 21
PY - Paraguay 21
GT - Guatemala 20
PK - Pakistan 20
TT - Trinidad e Tobago 19
AZ - Azerbaigian 18
KZ - Kazakistan 16
AU - Australia 15
NP - Nepal 15
KE - Kenya 14
MY - Malesia 14
PE - Perù 14
JO - Giordania 13
PH - Filippine 13
SA - Arabia Saudita 13
AL - Albania 11
HN - Honduras 11
TN - Tunisia 11
UY - Uruguay 10
AE - Emirati Arabi Uniti 9
SC - Seychelles 9
SV - El Salvador 8
CZ - Repubblica Ceca 7
DO - Repubblica Dominicana 7
EG - Egitto 7
GE - Georgia 7
GP - Guadalupe 7
LT - Lituania 7
SN - Senegal 7
CH - Svizzera 6
EE - Estonia 6
NO - Norvegia 6
OM - Oman 6
PA - Panama 6
RO - Romania 6
RS - Serbia 6
BO - Bolivia 5
GA - Gabon 5
KR - Corea 5
LB - Libano 5
LV - Lettonia 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
AO - Angola 4
BY - Bielorussia 4
CW - ???statistics.table.value.countryCode.CW??? 4
DZ - Algeria 4
IR - Iran 4
KG - Kirghizistan 4
LK - Sri Lanka 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BH - Bahrain 3
ET - Etiopia 3
EU - Europa 3
GR - Grecia 3
HU - Ungheria 3
Totale 29.508
Salva come PNG Salva come JPEG
Città #
Moscow 1.579
Ashburn 1.343
Singapore 1.336
Dublin 1.165
Chandler 934
Dallas 814
Jacksonville 765
San Jose 683
Hong Kong 626
Nyköping 502
Beijing 455
Council Bluffs 378
Princeton 219
The Dalles 214
Los Angeles 209
Lauterbourg 202
Dearborn 191
Cambridge 183
Des Moines 173
Messina 155
Medford 141
São Paulo 130
Buffalo 125
Boardman 112
Lancaster 112
Munich 105
Ho Chi Minh City 99
Warsaw 94
Ann Arbor 93
Santa Clara 89
Atlanta 72
Woodbridge 69
New York 67
Frankfurt am Main 60
Redondo Beach 60
Tianjin 59
Jinan 58
Rio de Janeiro 57
Hanoi 54
Wilmington 53
Bremen 49
Guangzhou 48
Shenyang 48
Phoenix 45
Belo Horizonte 43
Orem 43
San Mateo 41
Seattle 40
Brooklyn 39
Nuremberg 36
Houston 35
Turku 35
Tokyo 34
Columbus 33
Chicago 32
San Francisco 31
Rome 29
Chennai 28
Zhengzhou 28
Denver 27
North Bergen 27
Brasília 26
Curitiba 26
Hebei 26
London 26
Brussels 25
Shenzhen 25
Catania 24
Vienna 24
Nanjing 23
Ningbo 23
Campinas 22
Montreal 22
Tashkent 22
Shanghai 21
Amsterdam 20
Lawrenceville 20
Managua 20
San José 20
Walnut 20
Stockholm 19
Washington 19
Boston 18
Dhaka 18
Haikou 18
Helsinki 18
Changsha 17
Hangzhou 17
Johannesburg 17
Milan 17
Porto Alegre 17
Baghdad 16
Baku 16
Hyderabad 16
Manchester 16
Memphis 16
Mexico City 16
Bogotá 15
Düsseldorf 15
Kingston 15
Totale 15.377
Salva come PNG Salva come JPEG
Nome #
A three year pilo study with 1,25 dihydroxyvitamin D, calcium and calcitonin for severe osteodystrophy in primary biliary cirrhosis 299
Association between inflammatory bowel disease and sarcoidosis. Report of two cases and review of the literature 294
Osteopenia following total gastrectomy in the rat - state of mineral metabolism and bone histomorphometry 234
Diagnostic accuracy of faecal calprotectin in a symptom-based algorithm for early diagnosis of inflammatory bowel disease adjusting for differential verification bias using a Bayesian approach 230
Bone density and calcium metabolism in patients with long standing, quiescent Crohn's disease 229
Quality of life after proctocolectomy and ileo-anal anastomosis for severe ulcerative colitis 227
Bone metabolism in orthotopic liver transplantation: a prospective study 225
A protective effect of the synthetic coumarine derivative cloricromene on DNB-colitis in the rat. 224
Microradiographic anatomy of the explanted rat colon 220
Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis. 218
Effect of experimental colitis on bone metabolism in the rat 217
Optical coherence tomography evaluation of ulcerative colitis: The patterns and the comparison with histology 205
A protective effect of the synthetic coumarine derivative Cloricromene against DNB-colitis in the rat 203
Changing approach to gastroenteropancreatic tumours. Case report of a gastrinoma metastasis localised by somatostatin-receptor scintigraphy 202
The effect of heparin on trinitrobenzene sulphonic acid-induced colitis in the rat 200
A propensity score-matched comparison of infliximab and adalimumab in TNF-α inhibitors naïve and non-naïve patients with Crohn's disease: real-life data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD) 196
Impairment of bone and mineral metabolism after pancreas transplantation – Observations in the syngeneic rat. 195
Alexithymia and inflammatory bowel disease: A systematic review 195
Guide to magnetic resonance in Crohn's disease: from common findings to the more rare complicances. 193
Effects of jejuno-ileal bypass on oxalate and mineral metabolism. 191
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project 190
Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease. 189
Orchiectomy-induced osteoporosis in the rat – A preliminary report on the state of mineral and bone metabolism, and its response to oral calcium-sodium-citrate. 188
Disturbances of mineral and bone metabolism following gastric antrectomy in the rat. 188
Cancer risk in inflammatory bowel disease: a 6-year prospective multicenter nested case-control IG-IBD study 185
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study. 182
Azathioprine/6-Mercaptopurine in the treatment of inflammatory bowel disease (IBD)- A single centre experience. 178
Age is a Risk Factor for Severe Infections and Mortality in Patients given Anti-Tumor Necrosis Factor Therapy for Inflammatory bowel disease. 177
Adalimumab in Crohn's Disease: Tips and Tricks After 5 Years of Clinical Experience 177
OCT Performance in the Diagnosis of Ulcerative Colitis 174
Quality of life in inflammatory bowel disease. 170
Response evaluation and safety of thiopurines in the treatment of inflammatory bowel diseases (IBD): safety and response evaluation. 169
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease after Ileocolonic Resection 168
Oral beclomethasone diproprionate in pediatric active ulcerative colitis: a comparison trial with mesalazine. 168
A prospective comparison between CT enterography and MR enterography (MRE) in ileo-colonic Crohn’s disease: a single-center experience. 167
DWI ratios: New indexes for Crohn's disease activity at magnetic resonance enterography? 166
Combined approach with biologics and surgery for entero-cutaneous fistulas in Crohn’s disease 166
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab 166
Direct oral anticoagulants increase the risk of anaemia and hospitalization in IBD patients with active intestinal disease 166
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. 164
Azathioprine/6-Mercaptopurine in the treatment of inflammatory bowel disease (IBD)- A single centre experience 163
Fecal calprotectin correlates with intestinal permeabilità (IP) in patients with Crohn’s disease. 163
Anti-TNF Therapy in Elderly People in IBD: An Italian Multicentre Survey. 162
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study 162
Effectiveness of Ustekinumab on Crohn‘s Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) 162
A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis 161
Negative emotions in irritable bowel syndrome: which differences among IBS subtypes? 157
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 156
A “real life” experience of infliximab use for Crohn’s disease in southern Italy 155
Analisi molecolare dei geni TLR4 e CARD15/NOD2 in pazienti affetti da malattie infiammatorie croniche intestinali: dati preliminari in una popolazione del sud Italia 153
Association between previously identified disease loci at chr12q15 and chr1p36 and UC in Italian population 153
H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biologics. 153
Clinical significante of NOD2/CARD15 and TLR4 gene SNPs in inflammatory bowel disease 152
Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD “AGED study” 152
Gastric permeability of sucrose is increased in portal hypertensive gastropathy. 151
The aged gut in inflammatory bowel diseases. 151
Adalimumab In Active Ulcerative Colitis: A “Real-Life” Observational Study on behalf of the Italian Group for the study of Inflammatory Bowel Disease. 150
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 149
Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study 149
Hemophagocytic lymphohistiocytic (HLH) syndrome in IBD patients treated with thiopurines – a case series 148
Metacognitions and basic emotions in patients with irritable bowel syndrome and inflammatory bowel disease 148
Association Between Previously Identified Disease Loci At Chr12q15 and Chr1p36 and UC in Italian Population. 147
Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy. 147
Dysfunctional metacognitive beliefs and gastrointestinal disorders. Beyond an ‘organic’/‘functional’ categorization in the clinical practice. 146
Anti-TNF therapy in elderly people in IBD; an Italian multicentre survey 145
Early Post-Operative Endoscopic Recurrence in Crohn's Disease in an Italian Multicentric Cohort. 144
Urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in patients with Crohn’s disease undergoing treatment with infliximab. 144
Cytomegalovirus complicating Inflammatory Bowel Disease: Useful Remarks. 144
Hepatocyte tight-junctional permeability is increased in rat experimental colitis. 143
Serology of Viral Infections and Tuberculosis Screening in an IBD Population Referred to a Tertiary Centre of Southern Italy 143
Mucosal Immunology and Probiotics. 142
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis 142
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study 142
Clinical practice in the management of ulcerative colitis - an Italian survey 141
Gastric permeability to sucrose is increased in portal hypertensive gastropathy 141
Vitamin D and inflammatory bowel disease 141
Infliximab and etanercept are equally effective in reducing enterocyte apoptosis in experimental colitis. 140
IBD-associated bone loss: is inflammation the explanation? 139
Experimental colitis increases small intestine permeability in the rat 138
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: The IG-IBD LIVE study 138
Thalidomide for refractory bleeding small intestinal Crohn’s disease– a case report 137
Prevention of post-surgical recurrence with adalimumab in a patient with complicated Crohn's disease. 137
GASTROINTESTINAL PERMEABILITY IS INCRISED IN SCLERODERMA PATIENTS 136
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in southern Italy 136
Ileal tight junction (TJ) alterations associated with experimental colitis – a time course. 135
Hongos productores de biopelículas como causa emergente de infecciones por vía hemática en la enfermedad inflamatoria intestinal 135
Infliximab normalizes intestinal permeability in the short-term but not fecal calprotectin in Crohn’s disease 134
Efficacy and safety of long-term infliximab use for Crohn’s disease in Southern Italy. 134
Sealing The Broken Barrier in IBD: Intestinal Permeability, Epithelial Cells and Junctions. 134
Metacognition and negative emotions in clinical practice. A preliminary study with patients with bowel disorder 134
Acute onset of Lupus associated Pancreatitis Mimicking Pancreatic Cancer 134
A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis 134
Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs? 132
Contenuti metacognitivi e alessitimia in un gruppo di soggetti con disturbi gastrointestinali. Uno studio esplorativo 131
Gastric fundectomy in the rat - effects on mineral bone metabolism, with emphasis on the gastrin-calcitonin-parathyroid hormone-vitamin D axis 130
Gastro-intestinal permeability is increased in patients with limited systemic sclerosis 130
Efficacy and safety of long-term infliximab use for Crohn’s disease in Southern Italy. 130
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial 130
A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease 129
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial 128
Totale 16.512
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.020
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.020
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.138 0 0 0 0 45 15 62 46 15 333 194 428
2022/20233.388 301 272 153 299 284 319 39 177 1.404 17 89 34
2023/2024790 69 116 87 130 89 102 21 30 2 69 8 67
2024/20254.374 64 56 129 231 255 196 147 885 1.110 224 338 739
2025/202611.999 464 764 864 751 973 2.700 1.527 1.572 1.481 496 196 211
2026/20274.055 337 2.068 626 900 124 0 0 0 0 0 0 0
Totale 30.000